Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2025-12-29 @ 8:07 AM
Study NCT ID:
NCT02384395
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2015-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Sponsor:
University of North Carolina, Chapel Hill
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2020-03-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-04
First Submit QC Date:
None
Study First Post Date:
2015-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-28
Results First Submit QC Date:
None
Results First Post Date:
2021-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-22
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL